{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:27:35Z","timestamp":1792315655741,"version":"4.4.0"},"reference-count":31,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J Psychiatry Med"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Obsessive-compulsive disorder (OCD) is a prevalent and burdensome mental health condition, often resistant to conventional treatments. Agomelatine (Valdoxan), a compound acting on serotonin and melatonin systems, has shown promise in treating those with treatment-resistant OCD based on anecdotal reports and case studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A randomized, double-blind controlled trial was conducted with 60 patients diagnosed with treatment-resistant OCD. Participants were randomized into an intervention group (receiving agomelatine 50 mg\/day) and a control group (receiving placebo). OCD symptoms were assessed using the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) over a 12-week period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were no significant differences in age, gender, or baseline Y-BOCS scores between intervention and control groups. Agomelatine did not demonstrate a significant improvement in OCD symptoms compared to placebo. Adverse events were comparable between groups, and liver enzyme levels remained within the normal range.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study, while not confirming superior efficacy compared to placebo, underscores the need for continued investigation into agomelatine\u2019s potential for treating specific subgroups of OCD patients, underscoring the need for more comprehensive and well-controlled trials in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/00912174231225763","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T06:47:57Z","timestamp":1703832477000},"page":"545-555","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Agomelatine efficacy in treatment resistant obsessive-compulsive disorder: A randomized controlled trial"],"prefix":"10.1177","volume":"59","author":[{"given":"Azadeh","family":"Nejati","sequence":"first","affiliation":[{"name":"Research Center for Psychiatry and Behavioral Science, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Bazrafshan","sequence":"additional","affiliation":[{"name":"Substance Abuse Research Center, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2016-6836","authenticated-orcid":false,"given":"Seyed Hamdollah","family":"Mosavat","sequence":"additional","affiliation":[{"name":"Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"key":"bibr1-00912174231225763","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.703701"},{"key":"bibr2-00912174231225763","doi-asserted-by":"publisher","DOI":"10.1097\/PRA.0000000000000580"},{"key":"bibr3-00912174231225763","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2022.152342"},{"key":"bibr4-00912174231225763","doi-asserted-by":"publisher","DOI":"10.1002\/da.21996"},{"issue":"1","key":"bibr5-00912174231225763","first-page":"19","volume":"10","author":"Albert U","year":"2013","journal-title":"Clin Neuropsychiatry"},{"key":"bibr6-00912174231225763","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2022.152352"},{"key":"bibr7-00912174231225763","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2021-328738"},{"key":"bibr8-00912174231225763","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.19ac13182"},{"key":"bibr9-00912174231225763","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2020.594277"},{"key":"bibr10-00912174231225763","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2018.12.009"},{"key":"bibr11-00912174231225763","doi-asserted-by":"publisher","DOI":"10.1186\/1744-859X-10-5"},{"key":"bibr12-00912174231225763","doi-asserted-by":"publisher","DOI":"10.2174\/0929867325666171222163645"},{"key":"bibr13-00912174231225763","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X16666180813155017"},{"key":"bibr14-00912174231225763","volume-title":"The Use of Somatic Experiencing TM in the Treatment of an Adolescent with Trauma-Based Obsessive-Compulsive Disorder","author":"Berman AI","year":"2019"},{"key":"bibr15-00912174231225763","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.05.026"},{"key":"bibr16-00912174231225763","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2016.1181783"},{"key":"bibr17-00912174231225763","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12792"},{"key":"bibr18-00912174231225763","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-019-1033-0"},{"key":"bibr19-00912174231225763","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejbas.2016.07.001"},{"key":"bibr20-00912174231225763","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2020.03.021"},{"key":"bibr21-00912174231225763","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107402"},{"key":"bibr22-00912174231225763","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2015.01798"},{"key":"bibr23-00912174231225763","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.20111601"},{"key":"bibr24-00912174231225763","doi-asserted-by":"publisher","DOI":"10.1002\/wps.21056"},{"key":"bibr32-9009121742313","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-023-05189-7"},{"key":"bibr26-00912174231225763","doi-asserted-by":"publisher","DOI":"10.1016\/j.janxdis.2019.102173"},{"key":"bibr27-00912174231225763","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.332133"},{"key":"bibr28-00912174231225763","first-page":"642752","volume":"2012","author":"De Berardis D","year":"2012","journal-title":"Case Rep Psychiatry"},{"key":"bibr29-00912174231225763","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318249298c"},{"issue":"3","key":"bibr30-00912174231225763","first-page":"179","volume":"25","author":"Tzavellas E","year":"2014","journal-title":"Psychiatrike= Psychiatriki"},{"key":"bibr31-00912174231225763","doi-asserted-by":"publisher","DOI":"10.3390\/ijms16011111"}],"container-title":["The International Journal of Psychiatry in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00912174231225763","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00912174231225763","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00912174231225763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:12:48Z","timestamp":1777457568000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00912174231225763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1177\/00912174231225763"],"URL":"https:\/\/doi.org\/10.1177\/00912174231225763","relation":{},"ISSN":["0091-2174","1541-3527"],"issn-type":[{"value":"0091-2174","type":"print"},{"value":"1541-3527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,29]]}}}